Gene expression signatures associated with treatment and resistance to imatinib mesylate in chronic myeloid leukemia patients.

被引：0
|
作者：
Oehler, V
Branford, S
Pogosova-Agadjanyan, E
Shah, N
Sawyers, C
Mao, M
Linsley, P
Hughes, T
Radich, J
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[2] Univ Adelaide, Div Haematol, IMVS & Hanson Inst, Adelaide, SA, Australia
[3] Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA
[4] Rosetta Inpharmat, Seattle, WA USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131A / 131A
页数：1
相关论文
共 50 条
  • [1] Decreased Expression of microRNA-451 is Associated with Imatinib Mesylate Resistance in Chronic Myeloid Leukemia Patients
    Khalifa, Khaled
    Abbas, Omaima
    Abdlfattah, Raafat
    Alhassanin, Suzan
    Shehata, Amira
    Esawy, Sally
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S293 - S293
  • [2] Treatment of chronic myeloid leukemia with imatinib mesylate
    Ohno R.
    International Journal of Clinical Oncology, 2006, 11 (3) : 176 - 183
  • [3] Imatinib mesylate and treatment of chronic myeloid leukemia
    Yamada, Hisashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 39P - 39P
  • [4] Imatinib mesylate for the treatment of chronic myeloid leukemia
    Soverini, Simona
    Martinelli, Giovanni
    Lacobucci, Ilaria
    Baccarani, Michele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (06) : 853 - 864
  • [5] Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance
    Sandoval, C
    Giamelli, J
    Jayabose, S
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) : 507 - 508
  • [6] Imatinib Mesylate in Chronic Myeloid Leukemia
    Mishra, Pravas
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
  • [7] Alterations in Sialylation Patterns are Significantly Associated with Imatinib Mesylate Resistance in Chronic Myeloid Leukemia
    Patel, Kinjal D.
    De, Maitri
    Jethva, Disha D.
    Rathod, Bharati S.
    Patel, Prabhudas S.
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (01) : 51 - 58
  • [8] t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia
    Dencic-Fekete, Marija
    Dordevic, Vesna
    Storlazzi, Clelia Tiziana
    Jankovic, Gradimir
    Bogdanovic, Andrija
    Jovanovic, Jelica
    Rocchi, Mariano
    Todoric-Zivanovic, Biljana
    Strnad, Milica
    Gotic, Mirjana
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (04) : 508 - 512
  • [9] t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia
    Marija Denčić-Fekete
    Vesna Đorđević
    Clelia Tiziana Storlazzi
    Gradimir Janković
    Andrija Bogdanović
    Jelica Jovanović
    Mariano Rocchi
    Biljana Todorić-Živanović
    Milica Strnad
    Mirjana Gotić
    International Journal of Hematology, 2009, 89 : 508 - 512
  • [10] MULTIPLE PATHS TO DRUG RESISTANCE PHENOTYPE IN CHRONIC MYELOID LEUKEMIA PATIENTS UNDERGOING IMATINIB MESYLATE TREATMENT
    Ankathil, Ravindran
    Zahry, Mohd Khairi
    Hassan, Rosline
    Dzarr, Abu
    Peng, Hoh Boon
    Baba, Abdul Aziz
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3198 - 3198
12345